Mettler-Toledo International (NYSE:MTD) Reaches New 1-Year High on Analyst Upgrade

Mettler-Toledo International, Inc. (NYSE:MTD) shares reached a new 52-week high during mid-day trading on Tuesday after Citigroup raised their price target on the stock from $1,600.00 to $1,700.00. Citigroup currently has a buy rating on the stock. Mettler-Toledo International traded as high as $1,460.20 and last traded at $1,453.0910, with a volume of 24161 shares changing hands. The stock had previously closed at $1,432.57.

MTD has been the topic of a number of other research reports. Stifel Nicolaus boosted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday. Evercore ISI raised their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Finally, Barclays upped their target price on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research report on Monday. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,406.50.

Insider Buying and Selling

In other news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the sale, the director owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 1,527 shares of company stock worth $1,994,981. Corporate insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds have recently added to or reduced their stakes in MTD. Envestnet Asset Management Inc. lifted its position in shares of Mettler-Toledo International by 2.5% in the 1st quarter. Envestnet Asset Management Inc. now owns 15,823 shares of the medical instruments supplier’s stock worth $18,686,000 after buying an additional 393 shares during the last quarter. Cerity Partners LLC raised its stake in Mettler-Toledo International by 7.1% during the first quarter. Cerity Partners LLC now owns 3,643 shares of the medical instruments supplier’s stock worth $4,302,000 after acquiring an additional 242 shares during the period. Ballentine Partners LLC lifted its holdings in Mettler-Toledo International by 15.4% in the first quarter. Ballentine Partners LLC now owns 554 shares of the medical instruments supplier’s stock worth $654,000 after acquiring an additional 74 shares during the last quarter. CWM LLC boosted its stake in Mettler-Toledo International by 2.5% in the first quarter. CWM LLC now owns 657 shares of the medical instruments supplier’s stock valued at $776,000 after acquiring an additional 16 shares during the period. Finally, Edgestream Partners L.P. grew its holdings in shares of Mettler-Toledo International by 44.6% during the first quarter. Edgestream Partners L.P. now owns 8,431 shares of the medical instruments supplier’s stock valued at $9,956,000 after purchasing an additional 2,602 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

The company has a fifty day moving average price of $1,323.11 and a 200 day moving average price of $1,240.69. The company has a market capitalization of $29.78 billion, a P/E ratio of 36.57, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.